Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Hilton Kaplan, Aslam Amod, Francois H van Zyl, Jeevren Reddy, Alet van Tonder, Ellina Tsymbal & Alicia McMaster. (2019) Incidence of hypoglycaemia in the South African population with diabetes: results from the IDMPS Wave 7 study. Journal of Endocrinology, Metabolism and Diabetes of South Africa 24:2, pages 58-64.
Read now
Read now
Eric L. Johnson, Juan P. Frias & Jennifer M. Trujillo. (2018) Anticipatory guidance in type 2 diabetes to improve disease management; next steps after basal insulin. Postgraduate Medicine 130:4, pages 365-374.
Read now
Read now
Articles from other publishers (10)
Puhong Zhang, Yuqian Bao, Minyuan Chen, Heng Zhang, Dongshan Zhu, Linong Ji, Xian Li, Jiachao Ji, Fang Zhao, Edwin B. Fisher, Yang ZhaoNadila Duolikun, Du Wang & Weiping Jia. (2023) Changes of health-related quality of life after initiating basal insulin treatment among people with type 2 diabetes. Medicine 102:34, pages e34718.
Crossref
Crossref
Edward B. Jude, Maciej T. Malecki, Ricardo Gomez Huelgas, Martin Prazny, Frank Snoek, Tsvetalina Tankova, Dario Giugliano & Kamlesh Khunti. (2022) Expert Panel Guidance and Narrative Review of Treatment Simplification of Complex Insulin Regimens to Improve Outcomes in Type 2 Diabetes. Diabetes Therapy 13:4, pages 619-634.
Crossref
Crossref
Luigi Meneghini, Lawrence Blonde, Jasvinder Gill, Arnaud Dauchy, Andrius Bacevicius, Jodi Strong & Timothy S. Bailey. (2020)
Insulin glargine 300 U/
mL
versus first‐generation basal insulin analogues in insulin‐naïve adults with type 2 diabetes: 12‐month outcomes of
ACHIEVE
Control, a prospective, randomized, pragmatic real‐life clinical trial
. Diabetes, Obesity and Metabolism 22:11, pages 1995-2003.
Crossref
Crossref
John Anderson, Scott Urquhart, Geralyn Spollett & Paresh Dandona. (2020) Effective Initiation and Treatment With Basal Insulin in People With Type 2 Diabetes: Focus on Mitigating Hypoglycemia in Patients at Increased Risk: Executive Summary. Clinical Diabetes 38:4, pages 324-327.
Crossref
Crossref
Susan L. Karam, Jared Dendy, Shruti Polu & Lawrence Blonde. (2020) Overview of Therapeutic Inertia in Diabetes: Prevalence, Causes, and Consequences. Diabetes Spectrum 33:1, pages 8-15.
Crossref
Crossref
Pengxiang Li, Zhi Geng, Vrushabh P. Ladage, Jasmanda Wu, Ilona Lorincz & Jalpa A. Doshi. (2019) Early hypoglycaemia and adherence after basal insulin initiation in a nationally representative sample of Medicare beneficiaries with type 2 diabetes. Diabetes, Obesity and Metabolism 21:11, pages 2486-2495.
Crossref
Crossref
Timothy S. Bailey, Jasmanda Wu, Fang L. Zhou, Rishab A. Gupta, Arjun A. Menon, Paulos Berhanu, Jukka Westerbacka, John Van Vleet & Lawrence Blonde. (2019) Switching to insulin glargine 300 units/mL in real‐world older patients with type 2 diabetes (DELIVER 3). Diabetes, Obesity and Metabolism 21:11, pages 2384-2393.
Crossref
Crossref
Sean D. Sullivan, Timothy S. Bailey, Ronan Roussel, Fang Liz Zhou, Zsolt Bosnyak, Ronald Preblick, Jukka Westerbacka, Rishab A. Gupta & Lawrence Blonde. (2018) Clinical outcomes in real‐world patients with type 2 diabetes switching from first‐ to second‐generation basal insulin analogues: Comparative effectiveness of insulin glargine 300 units/mL and insulin degludec in the DELIVER D+ cohort study. Diabetes, Obesity and Metabolism 20:9, pages 2148-2158.
Crossref
Crossref
Luigi F. Meneghini, Lulu K. Lee, Shaloo Gupta & Ron Preblick. (2018) Association of hypoglycaemia severity with clinical, patient‐reported and economic outcomes in US patients with type 2 diabetes using basal insulin. Diabetes, Obesity and Metabolism 20:5, pages 1156-1165.
Crossref
Crossref
Vanita R. Aroda, Joseph R. Arulandu & Anthony J. Cannon. (2018) Insulin/Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy for the Treatment of Type 2 Diabetes: Are Two Agents Better Than One?. Clinical Diabetes 36:2, pages 138-147.
Crossref
Crossref